792 related articles for article (PubMed ID: 16105565)
1. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Zhanel GG; DeCorby M; Laing N; Weshnoweski B; Vashisht R; Tailor F; Nichol KA; Wierzbowski A; Baudry PJ; Karlowsky JA; Lagacé-Wiens P; Walkty A; McCracken M; Mulvey MR; Johnson J; ; Hoban DJ
Antimicrob Agents Chemother; 2008 Apr; 52(4):1430-7. PubMed ID: 18285482
[TBL] [Abstract][Full Text] [Related]
3. [Nosocomial bacterial infection in comprehensive intensive care unit].
Du B; Chen D; Liu D
Zhonghua Yi Xue Za Zhi; 1996 Apr; 76(4):262-6. PubMed ID: 8758270
[TBL] [Abstract][Full Text] [Related]
4. Comparison of susceptibility to beta-lactam antimicrobial agents among bacteria isolated from intensive care units.
Pierson CL; Friedman BA
Diagn Microbiol Infect Dis; 1992 Feb; 15(2 Suppl):19S-30S. PubMed ID: 1737439
[TBL] [Abstract][Full Text] [Related]
5. Trends in antimicrobial resistance among today's bacterial pathogens.
Thornsberry C
Pharmacotherapy; 1995; 15(1 Pt 2):3S-8S. PubMed ID: 7753690
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance of 100 serial gram-negative isolates in two intensive care units.
Leelarasamee A; Janyapoon K
J Med Assoc Thai; 1992 Dec; 75(12):680-7. PubMed ID: 1308536
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.
Klietmann W; Focht J; Nösner K
Chemioterapia; 1987 Aug; 6(4):243-50. PubMed ID: 3477332
[TBL] [Abstract][Full Text] [Related]
8. [Antibiotic sensitivity of gram-negative bacteria in intensive care units in Switzerland].
Wüst J; Auckenthaler R; Breer C; Frei R; Heinzer I; Kamm W
Schweiz Med Wochenschr; 1994 Oct; 124(39):1695-700. PubMed ID: 7939535
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activity of ciprofloxacin against aerobic and anaerobic bacteria from clinical isolates.
Klietmann W; Focht J; Nösner K
Arzneimittelforschung; 1987 Jun; 37(6):661-6. PubMed ID: 2822054
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of imipenem against 1386 clinical isolates.
Belobraydic KA; Qadri SM
Methods Find Exp Clin Pharmacol; 1986 Nov; 8(11):675-8. PubMed ID: 3468319
[TBL] [Abstract][Full Text] [Related]
11. Variation in potency and spectrum of tigecycline activity against bacterial strains from U.S. medical centers since its approval for clinical use (2006 to 2012).
Sader HS; Farrell DJ; Flamm RK; Jones RN
Antimicrob Agents Chemother; 2014; 58(4):2274-80. PubMed ID: 24492361
[TBL] [Abstract][Full Text] [Related]
12. [Urinary infection. I. Comparative in vitro activities of several antibiotic drugs against Gram-negative bacteria].
Giachino F; Allocco A; Tuninetti L; Tullio V; Cuffini AM; Carlone NA
G Batteriol Virol Immunol; 1992 Jan-1993 Dec; 85(1-12):55-67. PubMed ID: 7498617
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity patterns of bacteria isolated from patients at Sidamo Regional Hospital.
Lindtjorn B; Setegn D; Niemi M
Ethiop Med J; 1989 Jan; 27(1):27-31. PubMed ID: 2920709
[TBL] [Abstract][Full Text] [Related]
14. Agreement assessment of tigecycline susceptibilities determined by the disk diffusion and broth microdilution methods among commonly encountered resistant bacterial isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2008 to 2010.
Liu JW; Ko WC; Huang CH; Liao CH; Lu CT; Chuang YC; Tsao SM; Chen YS; Liu YC; Chen WY; Jang TN; Lin HC; Chen CM; Shi ZY; Pan SC; Yang JL; Kung HC; Liu CE; Cheng YJ; Chen YH; Lu PL; Sun W; Wang LS; Yu KW; Chiang PC; Lee MH; Lee CM; Hsu GJ; Hsueh PR
Antimicrob Agents Chemother; 2012 Mar; 56(3):1414-7. PubMed ID: 22155819
[TBL] [Abstract][Full Text] [Related]
15. Isepamicin (SCH 21420, 1-N-HAPA gentamicin B): microbiological characteristics including antimicrobial potency of spectrum of activity.
Jones RN
J Chemother; 1995 Jun; 7 Suppl 2():7-16. PubMed ID: 8622113
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and antibiotic sensitivity of Danish versus other European bacterial isolates from intensive care and hematology/oncology units.
Fomsgaard A; Høiby N; Friis HM; Gahrn-Hansen B; Kolmos HJ; Schouenborg P; Korsager B; Tvede M; Gutschik E; Bremmelgaard A
Eur J Clin Microbiol Infect Dis; 1995 Apr; 14(4):275-81. PubMed ID: 7649189
[TBL] [Abstract][Full Text] [Related]
17. [Microbiological study of nosocomial lung infections].
Araque-Granadillo MC; Nieves-Blanco BM
Rev Latinoam Microbiol; 1993; 35(2):147-52. PubMed ID: 8209107
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial activity of norfloxacin against 1700 relatively resistant clinical isolates.
Qadri SM; Lee G; Brodie L
Drugs Exp Clin Res; 1989; 15(8):349-53. PubMed ID: 2598776
[TBL] [Abstract][Full Text] [Related]
19. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
Drugs Exp Clin Res; 1987; 13(9):555-61. PubMed ID: 3480796
[TBL] [Abstract][Full Text] [Related]
20. Cefdinir: in vitro activity study and effect of human serum.
García-Rodríguez JA; Trujillano-Martín I; García-Sánchez JE
Drugs Exp Clin Res; 1993; 19(2):51-8. PubMed ID: 8223142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
